Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway
Xiaopeng Zhu, Hua Bian, Liu Wang, et al.
Free Radical Biology and Medicine (2019) Vol. 141, pp. 192-204
Closed Access | Times Cited: 195

Showing 1-25 of 195 citing articles:

New opportunities and challenges of natural products research: When target identification meets single-cell multiomics
Yuyu Zhu, Zijun Ouyang, Haojie Du, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 11, pp. 4011-4039
Open Access | Times Cited: 247
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
Xiaohan Xu, Kyle L. Poulsen, Lijuan Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 203
Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence
Xinmei Xu, Huan Yi, Jiasi Wu, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110984-110984
Open Access | Times Cited: 162
Treatment for liver cancer: From sorafenib to natural products
Shuli Man, Chen Luo, Mengyao Yan, et al.
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113690-113690
Closed Access | Times Cited: 138
Whole grain benefit: synergistic effect of oat phenolic compounds and β-glucan on hyperlipidemiaviagut microbiota in high-fat-diet mice
Ying Li, Chuan Qin, Lezhen Dong, et al.
Food & Function (2022) Vol. 13, Iss. 24, pp. 12686-12696
Closed Access | Times Cited: 84
SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors
Qin Sun, Xiaorui Xing, Huanyu Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115586-115586
Open Access | Times Cited: 45
Integrated network pharmacology, metabolomics, and transcriptomics of Huanglian-Hongqu herb pair in non-alcoholic fatty liver disease
Xiaobo Zhang, Jie Zhang, Zubing Zhou, et al.
Journal of Ethnopharmacology (2024) Vol. 325, pp. 117828-117828
Closed Access | Times Cited: 22
Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application
Yu Xu, Wei Guo, Cheng Zhang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 113
Phytopharmacology and Clinical Updates of Berberis Species Against Diabetes and Other Metabolic Diseases
Tarun Belwal, Aarti Bisht, Hari Prasad Devkota, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 86
The Synbiotic Combination of Akkermansia muciniphila and Quercetin Ameliorates Early Obesity and NAFLD through Gut Microbiota Reshaping and Bile Acid Metabolism Modulation
María Juárez‐Fernández, David Porras, Petar Petrov, et al.
Antioxidants (2021) Vol. 10, Iss. 12, pp. 2001-2001
Open Access | Times Cited: 85
Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes
Yanyan Wang, Xiqiao Zhou, Derrick Zhao, et al.
PLoS ONE (2020) Vol. 15, Iss. 5, pp. e0232630-e0232630
Open Access | Times Cited: 80
The pharmacological activity of berberine, a review for liver protection
Mengting Zhou, Ying Deng, Meichen Liu, et al.
European Journal of Pharmacology (2020) Vol. 890, pp. 173655-173655
Closed Access | Times Cited: 73
Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives
Xian-min Dai, Jiayi Feng, Yi Chen, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 60
The composition, pharmacological effects, related mechanisms and drug delivery of alkaloids from Corydalis yanhusuo
Jia-hua Feng, Kang Chen, Siyu Shen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115511-115511
Open Access | Times Cited: 28
Berberine prevents NAFLD and HCC by modulating metabolic disorders
Xinyue Lin, Jilei Zhang, Yajun Chu, et al.
Pharmacology & Therapeutics (2024) Vol. 254, pp. 108593-108593
Closed Access | Times Cited: 13
Biologically active isoquinoline alkaloids covering 2019–2022
Dengtuo Wang, Lulu Qin, Chen-Xin Jing, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107252-107252
Open Access | Times Cited: 10
Therapeutic Effects of Natural Products on Liver Cancer and Their Potential Mechanisms
Jinhong Guo, Wenjie Yan, Hao Duan, et al.
Nutrients (2024) Vol. 16, Iss. 11, pp. 1642-1642
Open Access | Times Cited: 9
BefA protein alleviates progression of non-alcoholic fatty liver disease by modulating the AMPK signaling pathway through the gut-liver axis
Jie Luo, Yujie Cai, Chao Jia, et al.
International Journal of Biological Macromolecules (2025) Vol. 294, pp. 139446-139446
Closed Access | Times Cited: 1
Total Saponins from Panax japonicus Reduced Lipid Deposition and Inflammation in Hepatocyte via PHD2 and Hepatic Macrophage-derived Exosomal miR-463-5p
Jingjie Yang, Yibei Gui, Ying Zheng, et al.
Journal of Ethnopharmacology (2025), pp. 119376-119376
Closed Access | Times Cited: 1
The emerging role of E3 ubiquitin ligases and deubiquitinases in metabolic dysfunction-associated steatotic liver disease
Yu Zhang, Jiahui Yang, Jiali Min, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Effect of molecular mass and sulfate content of fucoidan from Sargassum siliquosum on antioxidant, anti-lipogenesis, and anti-inflammatory activity
Chun‐Yen Chen, Shaohua Wang, Chih‐Yu Huang, et al.
Journal of Bioscience and Bioengineering (2021) Vol. 132, Iss. 4, pp. 359-364
Closed Access | Times Cited: 52
Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease
Honglin Zhou, Cheng Ma, Cheng Wang, et al.
European Journal of Pharmacology (2021) Vol. 898, pp. 173976-173976
Closed Access | Times Cited: 51
Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways
Yanyan Wang, Yunling Tai, Derrick Zhao, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 210-210
Open Access | Times Cited: 48
Astaxanthin from Haematococcus pluvialis alleviates obesity by modulating lipid metabolism and gut microbiota in mice fed a high-fat diet
Meng Wang, Haotian Ma, Siyu Guan, et al.
Food & Function (2021) Vol. 12, Iss. 20, pp. 9719-9738
Closed Access | Times Cited: 45
Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
Sa Yang, Shijie Cao, Congyu Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top